Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Phoenix New Media Limited

30.9% sales growth and 28.4% return on equity

Phoenix New Media Limited provides content on an integrated Internet platform in the People's Republic of China.

Phoenix New Media Limited’s sales growth this year is expected to be 10.2% and 12% for next year.

Year-on-year quarterly revenue growth declined by 20.3%, now sitting on N/A for the twelve trailing months.

Phoenix New Media Limited’s sales growth is a negative 0% for the ongoing quarter and 30.9% for the next. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.4%.

Volatility

Phoenix New Media Limited’s last day, last week, and last month’s average volatility was a negative 2.46%, a negative 19.66%, and a negative 4.49%, respectively.

Phoenix New Media Limited’s last day, last week, and last month’s high and low average amplitude percentage was 5.83%, 10.65%, and 6.18%, respectively.

Phoenix New Media Limited’s Stock Yearly Top and Bottom Value

Phoenix New Media Limited’s stock is valued at $1.20 at 16:22 EST, way under its 52-week high of $2.65 and higher than its 52-week low of $1.12.

Phoenix New Media Limited’s Moving Average

Phoenix New Media Limited’s worth is way under its 50-day moving average of $2.08 and way under its 200-day moving average of $1.63.

2. Marvell Technology Group Ltd.

15.6% sales growth and 19.01% return on equity

Marvell Technology Group Ltd.

Marvell Technology Group Ltd.’s sales growth this year is anticipated to be 9.6% and 16.8% for next year.

Year-on-year quarterly revenue growth grew by 13.2%, now sitting on 2.89B for the twelve trailing months.

Marvell Technology Group Ltd.’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the ongoing quarter and the next is 70.6% and 50%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.01%.

Volatility

Marvell Technology Group Ltd.’s last day, last week, and last month’s average volatility was 0.08%, 0.49%, and 0.09%, respectively.

Marvell Technology Group Ltd.’s last day, last week, and last month’s high and low average amplitude percentage was 1.55%, 2.50%, and 2.73%, respectively.

Marvell Technology Group Ltd.’s Stock Yearly Top and Bottom Value

Marvell Technology Group Ltd.’s stock is valued at $47.54 at 16:22 EST, below its 52-week high of $48.42 and way above its 52-week low of $16.45.

Marvell Technology Group Ltd.’s Moving Average

Marvell Technology Group Ltd.’s value is above its 50-day moving average of $45.12 and way higher than its 200-day moving average of $39.57.

3. Horizon Therapeutics Public Limited Company

34.3% sales growth and 29.59% return on equity

Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.

Horizon Therapeutics Public Limited Company’s sales growth this year is anticipated to be 64.1% and 27.3% for next year.

Year-on-year quarterly revenue growth grew by 89.7%, now sitting on 1.82B for the twelve trailing months.

Horizon Therapeutics Public Limited Company’s sales growth for the next quarter is 34.3%. The company’s growth estimates for the current quarter and the next is 82.1% and 32.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.59%.

Volatility

Horizon Therapeutics Public Limited Company’s last day, last week, and last month’s average volatility was 1.12%, 1.58%, and 0.30%, respectively.

Horizon Therapeutics Public Limited Company’s last day, last week, and last month’s high and low average amplitude percentage was 2.99%, 3.44%, and 3.86%, respectively.

Horizon Therapeutics Public Limited Company’s Stock Yearly Top and Bottom Value

Horizon Therapeutics Public Limited Company’s stock is valued at $73.15 at 16:22 EST, way under its 52-week high of $86.67 and way higher than its 52-week low of $23.81.

Horizon Therapeutics Public Limited Company’s Moving Average

Horizon Therapeutics Public Limited Company’s worth is above its 50-day moving average of $71.12 and above its 200-day moving average of $69.90.

4. Camtek Ltd.

37.3% sales growth and 13.15% return on equity

Camtek Ltd.

Camtek Ltd.’s sales growth this year is anticipated to be 12.2% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 140.44M for the twelve trailing months.

Camtek Ltd.’s sales growth for the next quarter is 37.3%. The company’s growth estimates for the ongoing quarter and the next is 35.7% and 88.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.15%.

Volatility

Camtek Ltd.’s last day, last week, and last month’s average volatility was 0.92%, 0.97%, and 0.71%, respectively.

Camtek Ltd.’s last day, last week, and last month’s high and low average amplitude percentage was 4.71%, 4.80%, and 4.14%, respectively.

Camtek Ltd.’s Stock Yearly Top and Bottom Value

Camtek Ltd.’s stock is valued at $21.91 at 16:22 EST, under its 52-week high of $22.64 and way above its 52-week low of $6.27.

Camtek Ltd.’s Moving Average

Camtek Ltd.’s value is way above its 50-day moving average of $19.67 and way above its 200-day moving average of $16.57.

5. American Water Works Company, Inc.

5.3% sales growth and 10.42% return on equity

American Water Works Company, Inc., through its subsidiaries, provides water and wastewater services in the United States.

American Water Works Company, Inc.’s sales growth this year is expected to be 5.5% and 4.9% for next year.

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 3.76B for the twelve trailing months.

American Water Works Company, Inc.’s sales growth for the next quarter is 5.3%. The company’s growth estimates for the present quarter and the next is 11% and 9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.42%.

Volatility

American Water Works Company, Inc.’s last day, last week, and last month’s average volatility was a positive 0.34%, a negative 0.08%, and a negative 0.11%, respectively.

American Water Works Company, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.36%, 1.54%, and 1.85%, respectively.

American Water Works Company, Inc.’s Stock Yearly Top and Bottom Value

American Water Works Company, Inc.’s stock is valued at $149.65 at 16:22 EST, way below its 52-week high of $172.56 and way above its 52-week low of $92.00.

American Water Works Company, Inc.’s Moving Average

American Water Works Company, Inc.’s worth is under its 50-day moving average of $153.93 and above its 200-day moving average of $145.61.

6. D.R. Horton, Inc.

30.4% sales growth and 21.24% return on equity

D.R. Horton, Inc. operates as a homebuilding company in East, Midwest, Southeast, South Central, Southwest, and West regions in the United States.

D.R. Horton, Inc.’s sales growth this year is anticipated to be 22.9% and 11.6% for next year.

Year-on-year quarterly revenue growth grew by 27%, now sitting on 20.31B for the twelve trailing months.

D.R. Horton, Inc.’s sales growth for the next quarter is 30.4%. The company’s growth estimates for the current quarter and the next is 44.8% and 41.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.24%.

Volatility

D.R. Horton, Inc.’s last day, last week, and last month’s average volatility was a negative 2.06%, a negative 0.80%, and a negative 0.37%, respectively.

D.R. Horton, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.56%, 2.65%, and 3.11%, respectively.

D.R. Horton, Inc.’s Stock Yearly Top and Bottom Value

D.R. Horton, Inc.’s stock is valued at $69.93 at 16:22 EST, way below its 52-week high of $81.21 and way higher than its 52-week low of $25.51.

D.R. Horton, Inc.’s Moving Average

D.R. Horton, Inc.’s worth is below its 50-day moving average of $72.36 and higher than its 200-day moving average of $69.21.

7. MorphoSys AG

179% sales growth and 12.31% return on equity

MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.

MorphoSys AG’s sales growth this year is expected to be 366.1% and a negative 31.1% for next year.

Year-on-year quarterly revenue growth grew by 76.4%, now sitting on N/A for the twelve trailing months.

MorphoSys AG’s sales growth for the next quarter is 179%. The company’s growth estimates for the present quarter and the next is a negative 0% and 61.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.31%.

Volatility

MorphoSys AG’s last day, last week, and last month’s average volatility was 1.13%, 0.91%, and 0.06%, respectively.

MorphoSys AG’s last day, last week, and last month’s high and low average amplitude percentage was 1.44%, 1.91%, and 1.86%, respectively.

MorphoSys AG’s Stock Yearly Top and Bottom Value

MorphoSys AG’s stock is valued at $28.66 at 16:22 EST, way under its 52-week high of $37.96 and way higher than its 52-week low of $18.21.

MorphoSys AG’s Moving Average

MorphoSys AG’s worth is higher than its 50-day moving average of $27.63 and below its 200-day moving average of $30.01.

LEAVE A REPLY

Please enter your comment!
Please enter your name here